Pathogenesis of systemic sclerosis-current concept and emerging treatments.
about
Dysregulated CD25 and Cytokine Expression by γδ T Cells of Systemic Sclerosis Patients Stimulated With Cardiolipin and Zoledronate.Inflammatory Mediators Drive Adverse Right Ventricular Remodeling and Dysfunction and Serve as Potential Biomarkers.Regulation of Cytokine Production by the Unfolded Protein Response; Implications for Infection and Autoimmunity.When the Benign Pneumatosis Intestinalis Becomes No Longer Benign: A Rare Case of Bowel Perforation in a Patient with Systemic SclerosisNRF2 Activation Inhibits Both TGF-1- and IL-13-Mediated Periostin Expression in Fibroblasts: Benefit of Cinnamaldehyde for Antifibrotic Treatment
P2860
Pathogenesis of systemic sclerosis-current concept and emerging treatments.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Pathogenesis of systemic sclerosis-current concept and emerging treatments.
@en
Pathogenesis of systemic sclerosis-current concept and emerging treatments.
@nl
type
label
Pathogenesis of systemic sclerosis-current concept and emerging treatments.
@en
Pathogenesis of systemic sclerosis-current concept and emerging treatments.
@nl
prefLabel
Pathogenesis of systemic sclerosis-current concept and emerging treatments.
@en
Pathogenesis of systemic sclerosis-current concept and emerging treatments.
@nl
P2093
P2860
P1433
P1476
Pathogenesis of systemic sclerosis-current concept and emerging treatments.
@en
P2093
Chikage Mitoma
Gaku Tsuji
Hiroki Mitoma
Hiroshi Uchi
Masutaka Furue
Takafumi Kadono
Takahito Chiba
Takeshi Nakahara
P2860
P2888
P304
P356
10.1007/S12026-017-8926-Y
P577
2017-05-09T00:00:00Z